This disclosure relates to catheter assemblies configured for treatment of a vessel bifurcation.
Catheters are used with stents and inflatable structures to treat conditions such as strictures, stenoses, and narrowing in various parts of the body. Various catheter designs have been developed for the dilatation of stenoses and to deliver and deploy stents at treatment sites within the body.
Stents are typically intraluminally placed by a catheter within a vein, artery, or other tubular shaped body organ for treating conditions such as, for example, occlusions, stenoses, aneurysms, dissections, or weakened, diseased, or abnormally dilated vessels or vessel walls, by expanding the vessels or by reinforcing the vessel walls. Once delivered, the stents can be expanded using one or more inflatable members such as balloons. Stents can improve angioplasty results by preventing elastic recoil and remodeling of the vessel wall and treating dissections in blood vessel walls caused by balloon angioplasty of coronary arteries. Stents can also be used as a drug delivery medium for treatment of damaged portions of a vessel.
While conventional stent technology is relatively well developed, stent technologies related to treatment of the region of a vessel bifurcation are still being developed.
The present disclosure relates to stent crimping systems and methods for use in preparing a bifurcation catheter assembly for use in a patient. One aspect of the present disclosure relates to a catheter assembly that includes main and side catheter branches and a stent. The stent includes a side branch aperture through which the side catheter branch extends. The stent is crimped onto the main and side catheter branches with a crimping mechanism in two crimping steps. In the first crimping step, only a distal end portion of the stent is crimped while the side catheter branch remains extending through the side branch opening of the stent and remains positioned outside of the crimping mechanism. In a second crimping step, the entire stent is crimped with the crimping mechanism.
Another aspect of the present disclosure relates to a recess feature defined in the crimping mechanism. The crimping mechanism includes a plurality of radially moveable crimping members that define a crimping chamber and a side surface. A recess can be defined in the side surface. The recess can be sized to receive a distal end portion of the side catheter branch during the first crimping step.
There is no requirement that an arrangement include all features characterized herein to obtain some advantage according to this disclosure.
This disclosure relates to bifurcation treatment systems, catheter assemblies, methods of assembling such bifurcation treatment systems and assemblies, and related devices and apparatuses for use in such methods. The term bifurcation means a division location from one unit into two or more units. Generally, two types of bifurcations of a body organ include: 1) a main tubular member defining a main lumen and a branch tubular member defining a branch lumen that extends or branches off from the main tubular member, wherein the main and branch lumens are in fluid communication with each other, and 2) a primary or main member defining a primary or main lumen (also referred to as a parent lumen) that splits into first and second branch members defining first and second branch lumens. The term lumen means the cavity or bore of a tubular structure such as a tubular organ (e.g., a blood vessel).
An example bifurcation is a vessel bifurcation that includes a continuous main vessel and a branch vessel, wherein the vessels define a main lumen and a branch lumen, respectively that are in fluid communication with each other. Alternatively, a vessel bifurcation can include a parent vessel that divides into first and second branch vessels, wherein the vessels define a parent lumen and first and second branch lumens, respectively, which lumens are all in fluid communication with each other.
Example applications of the inventive principles disclosed herein include cardiac, coronary, renal, peripheral vascular, gastrointestinal, pulmonary, urinary, and neurovascular systems.
The systems, apparatuses and methods disclosed herein can be used to assemble all or portions of various bifurcation treatment systems and assemblies. One example step in the assembly of a bifurcation treatment system includes crimping a stent onto a pair of catheter branches—a main catheter branch and a side catheter branch. The main catheter branch includes a main balloon, a side balloon configured to extend radially outward relative to the main balloon when inflated, and a main guidewire housing. The side catheter branch defines a branch guidewire housing and is arranged to extend through a side branch opening of the stent. The side branch opening of the stent is defined in a sidewall of the stent at a location between distal and proximal open ends of the stent. In some assembly systems and methods, three or more applications of a crimping force to the stent via a crimping assembly is required to properly crimp the stent without causing damage to the main and branch vessels.
In one arrangement, the side catheter branch must be removed from the stent prior to initial crimping of a distal portion of the stent onto the main catheter branch. In a second crimping step, the side catheter branch is inserted through the side branch opening of the stent and then only the proximal portion of the stent is crimped onto the main and side catheter branches. In a third crimping step, the entire stent is crimped onto the main and side catheter branches to help reduce a profile of the stent particularly in the area of the side branch opening.
The use of three or more separate crimping steps adds significant time and complexity to the process of assembling and crimping a bifurcation catheter assembly. Further, a crimping process that includes removal of the side catheter branch from the stent during or between any one of the crimping steps typically requires that the side catheter branch is disconnected from the main catheter branch. This reduces the possibility of certain bonding arrangements for connection of the side catheter branch to the main catheter branch at a location proximal of the stent. Such a proximal bond is desirable in some dual monorail (e.g., dual rapid exchange (Rx)) catheter systems and bifurcation catheter assemblies. Bond arrangements possible post-crimping of the stent are usually limited to adhesive bonds. Bonding arrangements requiring application of heat (e.g., heat bonding and laser bonding) sometimes cannot be used in close proximity to a stent. Bonding the side catheter branch to the main catheter branch after crimping the stent can also inhibit opportunities to conduct positive pressure testing of the main and side catheter branches, since application of a positive pressure to the catheter assembly after the stent is crimped thereto tends to re-expand the stent.
The Example Apparatuses and Assembly Methods of
Referring now to
The process or method of assembling the catheter assembly 10 and crimping stent 16 into the package shown in
The side catheter branch 14 can be connected to the main catheter branch 12 at a location proximal of the main balloon 34 and typically within a range of about 10 to about 100 mm from the main balloon 34 to facilitate a dual monorail catheter system arrangement. Providing such a proximal bond between the main and side catheter branches 12, 14 permits positive pressure testing of the catheter assembly 10 prior to crimping the stent 16. Vacuum pressure testing of the catheter assembly 10 can be conducted after formation of the proximal bond and prior to or after the crimping step.
Typically, the first and second mandrels 22, 24 are extended from distal ends of the main guidewire housing 32 and the side catheter branch 14 a distance in the range of about 5 to about 40 mm, and more preferably in the range of about 20 to about 30 mm. The main guidewire housing 32 typically extends through an interior of the main balloon 34 and into the catheter shaft 30. A space defined between the main guidewire housing 32 and an interior of the catheter shaft 30 can define an inflation lumen that provides delivery of inflation fluid to the main and side balloons 34, 42, and deflation thereof. The main guidewire housing 32 and the side catheter branch 14 define main and branch guidewire lumens sized to receive main and branch guidewires 18, 19 (see
There are many stent constructions possible for stent 16. Some example stent constructions are disclosed in U.S. Published Patent Application Nos. 2004/0267352 and 2006/0036315, which are incorporated herein by reference in their entirety.
With the main and side catheter branches 12, 14 positioned within the stent 16 with the side catheter branch 14 extending out of the side branch opening 88, the second mandrel 24 is retracted proximally until a distal end 26 thereof is positioned in alignment with the side branch opening 88. Positioning of the mandrel 24 in this orientation permits bending or other radial or lateral movement of the side catheter branch distal end 48 relative to the main catheter branch 12 and stent 16. Movement of the distal end 48 while maintaining the remaining portions of the side catheter branch 14 fixed relative to the main catheter branch 12 can help in interfacing with a crimping mechanism 50 to provide crimping of the distal end portion 80 of the stent 16.
The catheter assembly 10 with the bent distal end 48 of the side catheter branch 14 is then inserted into a crimping mechanism 50 as shown in
A distal end of the catheter assembly 10 is inserted distally into the core 54 up to the point of the side branch opening 88 of the stent 16. The distal end portion 80 of the stent 16 along with the distal end portion 36 of the main balloon 34 and the distal inflation segment 44 of the side balloon arrangement 44 and distal portions of the main guidewire housing 32 are all positioned within the core 54. The pre-bent shape of the side catheter branch 14 as shown in
With the catheter assembly 10 arranged as shown in
Typically, the amount of force applied by the crimping mechanism 50 during the crimping steps shown and described with reference to
In further steps of preparing the catheter assembly 10 for application in a patient can include removing the first and second mandrels 22, 24 from the catheter assembly 10 and replacing mandrels 22, 24 with product application mandrels (not shown). A further step can include applying a balloon protecting sleeve over portions of the catheter assembly 10, particularly in the area of the main and side balloons 34, 42. The catheter assembly 10 can also be positioned within a guiding catheter prior to use in a patient.
With the catheter assembly 10 properly aligned relative to the vessel bifurcation 70, the main balloon 34 is inflated to expand the stent into engagement with the main vessel 72, and the side balloon 42 is inflated to expand the expandable members 90 of the stent 16 through the ostium 76 and into at least partial engagement with the branch vessel 74. The balloons 34, 42 are then deflated and the main and side catheter branches 12, 14 are retracted proximally from the stent 16. Further treatment of the vessel bifurcation 70 can be performed by advancing a post dilation balloon through the side branch opening 88 to inflate it and further expand the expandable members 90 into engagement with the branch vessel 74. In still further treatment steps, a secondary stent can be advanced through the side branch opening 88 and into the branch vessel 74. The secondary stent can be expanded into engagement with the branch vessel 74 and at least partially overlaps the expandable members 90.
Further Examples and Arrangements of
The crimping mechanism can have features that can help reduce the bent angle of the side catheter branch 14 during the first crimping step shown in
The recessed portion 58 provides a space within which the distal end portion 48 of the side catheter branch 14 can extend during the first crimping step shown in
The recessed portions 58, 158 described herein are defined relative to a front face 56 that is arranged generally perpendicular to a longitudinal axis of the crimping mechanism 150. In other arrangements, the front face 56 its can be arranged at a non-perpendicular angle relative to the longitudinal axis of the crimping mechanism 150.
Other constructions for crimping mechanisms are described in U.S. Pat. No. 7,225,518, which discloses different core constructions and other features related to crimping mechanisms. U.S. Pat. No. 7,225,518 patent is incorporated herein by reference.
The mandrel 124 can be inserted into the side catheter branch 14, typically through the distal end portion 48 prior to or after positioning of the side catheter branch 14 within the stent 16 and extending through the side branch opening 88. The mandrel 124 can be removed from the side catheter branch 14 after the first crimping step and prior to insertion of the second mandrel 24 into the side catheter branch 14 (see
The angle α can vary depending on, for example, the construction of the crimping mechanism 50. When the crimping mechanism includes a recess portion (see crimping mechanism 150 described with reference to
In other arrangements, the second mandrel 124 can include more than one bend or angled portion 128. For example, one angled portion can be arranged at the side branch opening 88, while a second angled portion can be arranged distal of the side branch opening 88 along the length of the side catheter branch 14. The second angled portion can be positioned at, for example, a location that would provide improved positioning of the distal end portion 48 within the recessed portion 58 of the crimping mechanism 150.
The example catheter assembly 10 described above with reference to
Materials and Other Considerations
The example systems disclosed herein may be used in over-the-wire or rapid exchange systems. Some example rapid exchanges systems are disclosed in U.S. Published Patent Application No. 2003/0181923 to Vardi et al., which application is incorporated herein by reference.
The materials used in the balloons, catheter shafts, and guidewire housing members disclosed herein can be made of any suitable material including, for example, thermoplastic polymers, polyethylene (high density, low density, intermediate density, linear low density), various co-polymers and blends of polyethylene, ionomers, polyesters, polycarbonates, polyamides, poly-vinyl chloride, acrylonitrile-butadiene-styrene copolymers, polyether-polyester copolymers, and polyetherpolyamide copolymers. One suitable material is Surlyn®, a copolymer polyolefin material (DuPont de Nemours, Wilmington, Del.). Still further suitable materials include thermoplastic polymers and thermoset polymeric materials, poly(ethylene terephthalate) (commonly referred to as PET), thermoplastic polyamide, polyphenylene sulfides, polypropylene. Some other example materials include polyurethanes and block copolymers, such as polyamide-polyether block copolymers or amide-tetramethylene glycol copolymers. Additional examples include the PEBAX® (a polyamide/polyether/polyester block copolymer) family of polymers, e.g., PEBAX® 70D, 72D, 2533, 5533, 6333, 7033, or 7233 (available from Elf AtoChem, Philadelphia, Pa.). Other examples include nylons, such as aliphatic nylons, for example, Vestamid L21011F, Nylon 11 (Elf Atochem), Nylon 6 (Allied Signal), Nylon 6/10 (BASF), Nylon 6/12 (Ashley Polymers), or Nylon 12. Additional examples of nylons include aromatic nylons, such as Grivory (EMS) and Nylon MXD-6. Other nylons and/or combinations of nylons can also be used. Still further examples include polybutylene terephthalate (PBT), such as CELANEX® (available from Ticona, Summit, N.J.), polyester/ether block copolymers such as ARNITEL® (available from DSM, Erionspilla, Ind.), e.g., ARNITEL® EM740, aromatic amides such as Trogamid (PA6-3-T, Degussa), and thermoplastic elastomers such as HYTREL® (Dupont de Nemours, Wilmington, Del.). In some embodiments, the PEBAX®, HYTREL®, and ARNITEL® materials have a Shore D hardness of about 45D to about 82D. The balloon materials can be used pure or as blends. For example, a blend may include a PBT and one or more PBT thermoplastic elastomers, such as RITEFLEX® (available from Ticona), ARNITEL®, or HYTREL®, or polyethylene terephthalate (PET) and a thermoplastic elastomer, such as a PBT thermoplastic elastomer. Additional examples of balloon material can be found in U.S. Pat. No. 6,146,356. It should be understood that the specific materials disclosed below for the individual embodiments does not limit the embodiment to those materials.
In the example catheter assemblies described above, some of the features can include a lubricious coating on an exterior surface thereof. The coating can promote insertion of the branch balloon into the branch vessel of a vessel bifurcation. The coating can also improve removal of the branch balloon from the branch vessel and the branch aperture of the stent when deflating and removing the catheter assembly from the vessel bifurcation after expansion of the stent. Some example coating for use with the branch balloon include hydrophilic polymers such as polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxyl alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers can be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coating with suitable lubricity, bonding and solubility. In some examples, portions of the devices described herein can be coated with a hydrophilic polymer or a fluoropolymer such as polytetrafluoroethylene (PTFE), better known as TEFLON®.
While the example stent delivery systems described above illustrate a balloon expandable stent having a predetermined side opening (i.e., branch aperture), other types of stents can be used with the catheter features described above. A variety of stents can be used with the systems and methods disclosed herein. Examples of such stents can be found in, for example, in U.S. Pat. Nos. 6,210,429 and 6,325,826 to Vardi et al., and co-pending U.S. patent application Ser. No. 10/644,550, filed on Aug. 21, 2003, and titled “Stent With a Protruding Branch Portion For Bifurcated Vessels,” the entire contents of which are incorporated herein by reference. In general, the aforementioned stents have a tubular shape with a continuous sidewall that extends between the proximal and distal ends. Proximal and distal stent apertures are defined at respective proximal and distal ends of the stent. A branch aperture is defined in the sidewall of the stent. The branch aperture provides access between an interior of the stent and an exterior of the stent. In some stents, the branch aperture includes expandable structure around a peripheral edge thereof that expands in a generally radial outward direction relative to a longitudinal axis of the stent. The expandable structure can be configured to extend into the branch lumen of the bifurcation upon expansion of the stent. The stent includes a plurality of strut structures that define the sidewall. The struts are expandable from a first, unexpanded state to a second, expanded state. Typically, the stent is configured to maintain the expanded state. The struts define a plurality of cell openings or cells along a length of the stent. The size and shape of the cells is typically different than the size and shape of the branch aperture. The stent is typically expanded once the stent is properly positioned in the main lumen of the bifurcation with the branch aperture aligned radially and axially with an opening into the branch lumen. The stent, including the expandable structure surrounding the branch aperture, can be expanded with a single expansion or with multiple expansions using, for example, one or more inflatable balloons.
One aspect of the present disclosure relates to a method of crimping a stent of a catheter assembly with a stent contracting assembly. The catheter assembly includes a main catheter branch, a side catheter branch, and a stent. The stent includes a proximal open end, a distal open end, and a side branch opening located between the proximal and distal open ends. The side catheter branch extends into the proximal open end of the stent and out of the side branch opening, and the main catheter branch extends into the proximal open end of the stent and out of the distal open end of the stent. The stent contracting assembly defines an outer profile reduction chamber and a side surface. One step of the method includes inserting the catheter assembly into the chamber until a distal portion of the stent up to a location distal of the side branch opening of the stent is positioned in the chamber, while the side catheter branch remains positioned outside of the chamber. The method also includes reducing an outer profile of the distal portion of the stent, inserting the entire stent into the chamber, and reducing an outer profile of a proximal portion of the stent.
Another aspect of the present disclosure relates to a stent contracting assembly. The assembly includes a plurality of moveable contracting members that define a stent crimping chamber that is constructed and arranged to receive at least a portion of a catheter assembly. The stent crimping chamber is configured to reduce an outer profile of a stent of the catheter assembly. The stent crimping chamber includes a longitudinal axis, and the plurality of moveable contracting members define a side surface of the stent contracting assembly. The side surface is arranged generally perpendicular to the longitudinal axis. A recess is defined in the side surface. The recess is sized to receive a portion of the catheter assembly when reducing an outer profile of a portion of the stent.
Another aspect of the present disclosure relates to a method of crimping a stent of a catheter assembly with a stent contracting assembly. The catheter assembly includes a main catheter branch, a side catheter branch, and a stent. The stent includes a proximal open end, a distal open end, and a side branch opening located between the proximal and distal open ends. The side catheter branch extends out of the side branch opening, and the main catheter branch extends through the stent from the proximal open end to the distal open end. The stent contracting assembly defines an outer profile reduction chamber. The method can include inserting portions of the catheter assembly into the chamber, and reducing an outer profile of the stent in only two activations of the stent contracting assembly to reduce a size of the chamber.
The above specification, examples and data provide a complete description of the manufacture and use of the composition of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention resides in the claims hereinafter appended.
Number | Name | Date | Kind |
---|---|---|---|
3792603 | Orain | Feb 1974 | A |
4448195 | LeVeen et al. | May 1984 | A |
4461163 | Kralowetz | Jul 1984 | A |
4484585 | Baier | Nov 1984 | A |
4578982 | Schrock | Apr 1986 | A |
4601701 | Mueller, Jr. | Jul 1986 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4913141 | Hillstead | Apr 1990 | A |
4994071 | MacGregor | Feb 1991 | A |
4998923 | Samson et al. | Mar 1991 | A |
5019085 | Hillstead | May 1991 | A |
5092152 | Miller et al. | Mar 1992 | A |
5122154 | Rhodes | Jun 1992 | A |
5195984 | Schatz | Mar 1993 | A |
5219355 | Parodi et al. | Jun 1993 | A |
5261263 | Whitesell | Nov 1993 | A |
5316023 | Palmaz et al. | May 1994 | A |
5397305 | Kawula et al. | Mar 1995 | A |
5449353 | Watanabe et al. | Sep 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5571086 | Kaplan et al. | Nov 1996 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5632763 | Glastra | May 1997 | A |
5643278 | Wijay | Jul 1997 | A |
5644945 | Baldwin et al. | Jul 1997 | A |
5672169 | Verbeek | Sep 1997 | A |
5681345 | Euteneuer | Oct 1997 | A |
5683345 | Waksman et al. | Nov 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5725519 | Penner et al. | Mar 1998 | A |
5749825 | Fischell et al. | May 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755735 | Richter et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5772669 | Vrba | Jun 1998 | A |
5776142 | Gunderson | Jul 1998 | A |
5788707 | Del Toro et al. | Aug 1998 | A |
5797952 | Klein | Aug 1998 | A |
5824055 | Spiridigliozzi et al. | Oct 1998 | A |
5833694 | Poncet | Nov 1998 | A |
5873906 | Lau et al. | Feb 1999 | A |
5876374 | Alba et al. | Mar 1999 | A |
5893868 | Hanson et al. | Apr 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5906759 | Richter | May 1999 | A |
5908405 | Imran et al. | Jun 1999 | A |
5921995 | Kleshinski | Jul 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5941908 | Goldsteen et al. | Aug 1999 | A |
5944727 | Ahari et al. | Aug 1999 | A |
5951569 | Tuckey et al. | Sep 1999 | A |
5957929 | Brenneman | Sep 1999 | A |
5957941 | Ream | Sep 1999 | A |
5961546 | Robinson et al. | Oct 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5968052 | Sullivan, III et al. | Oct 1999 | A |
6013092 | Dehdashtian et al. | Jan 2000 | A |
6017362 | Lau | Jan 2000 | A |
6027460 | Shturman | Feb 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6056722 | Jayaraman | May 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059813 | Vrba et al. | May 2000 | A |
6066155 | Amann et al. | May 2000 | A |
6071286 | Mawad | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6082990 | Jackson et al. | Jul 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6096045 | Del Toro et al. | Aug 2000 | A |
6096073 | Webster et al. | Aug 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6110191 | Dehdashtian et al. | Aug 2000 | A |
6117156 | Richter et al. | Sep 2000 | A |
6120522 | Vrba et al. | Sep 2000 | A |
6132450 | Hanson et al. | Oct 2000 | A |
6143014 | Dehdashtian et al. | Nov 2000 | A |
6146415 | Fitz | Nov 2000 | A |
6152944 | Holman et al. | Nov 2000 | A |
6165195 | Wilson et al. | Dec 2000 | A |
6165210 | Lau et al. | Dec 2000 | A |
6176116 | Wilhelm et al. | Jan 2001 | B1 |
6178802 | Reynolds | Jan 2001 | B1 |
6187015 | Brenneman | Feb 2001 | B1 |
6190360 | Iancea et al. | Feb 2001 | B1 |
6190393 | Bevier et al. | Feb 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6210431 | Power | Apr 2001 | B1 |
6214036 | Letendre et al. | Apr 2001 | B1 |
6221090 | Wilson | Apr 2001 | B1 |
6221097 | Wang et al. | Apr 2001 | B1 |
6224587 | Gibson | May 2001 | B1 |
6238410 | Vrba et al. | May 2001 | B1 |
6246914 | de la Rama et al. | Jun 2001 | B1 |
6254593 | Wilson | Jul 2001 | B1 |
6258052 | Milo | Jul 2001 | B1 |
6258073 | Mauch | Jul 2001 | B1 |
6264688 | Herklotz et al. | Jul 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6287277 | Yan | Sep 2001 | B1 |
6287330 | Johansson et al. | Sep 2001 | B1 |
6290673 | Shanley | Sep 2001 | B1 |
6299636 | Schmitt et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6319275 | Lashinski et al. | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6331186 | Wang et al. | Dec 2001 | B1 |
6342066 | Toro et al. | Jan 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6360577 | Austin | Mar 2002 | B2 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6361555 | Wilson | Mar 2002 | B1 |
6364893 | Sahatjian et al. | Apr 2002 | B1 |
6371978 | Wilson | Apr 2002 | B1 |
6375660 | Fischell et al. | Apr 2002 | B1 |
6379372 | Dehdashtian et al. | Apr 2002 | B1 |
6387117 | Arnold, Jr. et al. | May 2002 | B1 |
6387120 | Wilson et al. | May 2002 | B2 |
6391050 | Broome | May 2002 | B1 |
6406487 | Brenneman | Jun 2002 | B2 |
6406489 | Richter et al. | Jun 2002 | B1 |
6416529 | Holman et al. | Jul 2002 | B1 |
6436104 | Hojeibane | Aug 2002 | B2 |
6443880 | Blais et al. | Sep 2002 | B2 |
6443980 | Wang et al. | Sep 2002 | B1 |
6475166 | Escano | Nov 2002 | B1 |
6478814 | Wang et al. | Nov 2002 | B2 |
6482211 | Choi | Nov 2002 | B1 |
6488694 | Lau et al. | Dec 2002 | B1 |
6508835 | Shaolian et al. | Jan 2003 | B1 |
6510722 | Ching et al. | Jan 2003 | B1 |
6514261 | Randall et al. | Feb 2003 | B1 |
6514281 | Blaeser et al. | Feb 2003 | B1 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6520983 | Colgan et al. | Feb 2003 | B1 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6530947 | Euteneuer et al. | Mar 2003 | B1 |
6533805 | Jervis | Mar 2003 | B1 |
6540719 | Bigus et al. | Apr 2003 | B2 |
6544278 | Vrba et al. | Apr 2003 | B1 |
6554841 | Yang | Apr 2003 | B1 |
6568235 | Kokish | May 2003 | B1 |
6582459 | Lau et al. | Jun 2003 | B1 |
6589262 | Honebrink et al. | Jul 2003 | B1 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6599315 | Wilson | Jul 2003 | B2 |
6602226 | Smith et al. | Aug 2003 | B1 |
6607506 | Kletschka | Aug 2003 | B2 |
6607552 | Hanson | Aug 2003 | B1 |
6613067 | Johnson | Sep 2003 | B1 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6629350 | Motsenbocker | Oct 2003 | B2 |
6629981 | Bui et al. | Oct 2003 | B2 |
6651478 | Kokish | Nov 2003 | B1 |
6660030 | Shaolian et al. | Dec 2003 | B2 |
6669718 | Besselink | Dec 2003 | B2 |
6692483 | Vardi et al. | Feb 2004 | B2 |
6695862 | Cox et al. | Feb 2004 | B2 |
6699275 | Knudson et al. | Mar 2004 | B1 |
6739033 | Hijlkema et al. | May 2004 | B2 |
6925847 | Motsenbocker | Aug 2005 | B2 |
7225518 | Eidenschink et al. | Jun 2007 | B2 |
7314480 | Eidenschink et al. | Jan 2008 | B2 |
7367989 | Eidenschink | May 2008 | B2 |
20010001890 | Austin | May 2001 | A1 |
20010049548 | Vardi et al. | Dec 2001 | A1 |
20020019664 | Douglas | Feb 2002 | A1 |
20020019665 | Dehdashtian et al. | Feb 2002 | A1 |
20020022874 | Wilson | Feb 2002 | A1 |
20020038140 | Yang et al. | Mar 2002 | A1 |
20020038141 | Yang et al. | Mar 2002 | A1 |
20020072755 | Bigus et al. | Jun 2002 | A1 |
20020111675 | Wilson | Aug 2002 | A1 |
20020116045 | Eidenschink | Aug 2002 | A1 |
20020120320 | Wang et al. | Aug 2002 | A1 |
20020138966 | Motsenbocker | Oct 2002 | A1 |
20030023298 | Jervis | Jan 2003 | A1 |
20030055483 | Gumm | Mar 2003 | A1 |
20030055484 | Lau et al. | Mar 2003 | A1 |
20030144671 | Brooks et al. | Jul 2003 | A1 |
20030181923 | Vardi | Sep 2003 | A1 |
20030192164 | Austin | Oct 2003 | A1 |
20030195546 | Solar et al. | Oct 2003 | A1 |
20040138737 | Davidson et al. | Jul 2004 | A1 |
20040199239 | Austin et al. | Oct 2004 | A1 |
20040260379 | Jagger et al. | Dec 2004 | A1 |
20040267352 | Davidson et al. | Dec 2004 | A1 |
20050149161 | Eidenschink et al. | Jul 2005 | A1 |
20050154442 | Eidenschink et al. | Jul 2005 | A1 |
20050154450 | Larson et al. | Jul 2005 | A1 |
20050182473 | Eidenschink et al. | Aug 2005 | A1 |
20050183259 | Eidenschink et al. | Aug 2005 | A1 |
20050273149 | Tran et al. | Dec 2005 | A1 |
20060036315 | Yadin et al. | Feb 2006 | A1 |
20060100694 | Globerman | May 2006 | A1 |
20080086191 | Valencia et al. | Apr 2008 | A1 |
Number | Date | Country |
---|---|---|
29701758 | Mar 1997 | DE |
2678508 | Jan 1993 | FR |
0121076 | Mar 2001 | WO |
0121103 | Mar 2001 | WO |
0211646 | Feb 2002 | WO |
03017872 | Mar 2003 | WO |
03055414 | Jul 2003 | WO |
03061529 | Jul 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20090287289 A1 | Nov 2009 | US |